Related Experiment Video
Updated: Oct 1, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B
Wataru Matsuyama1, Masanori Nakagawa, Hiroshi Takashima
1Third Department of Internal Medicine, Kagoshima University Faculty of Medicine, Sakuragaoka 8-35-1, Kagoshima City 890-8520, Japan.
Abstract:
We previously reported familial cases characterized by Charcot-Marie-Tooth disease (CMT) phenotype with abnormal myelin foldings and MPZ Ile62Phe mutation. To further clarify the molecular mechanisms in this family, we produced wild-type MPZ, Ile62Phe mutant and other mutations in the neighboring regions producing thin myelin sheaths (Ser63del, Ser63Cys and Ser63Phe) by site-specific mutagenesis and transfected these into rat pheochromocytoma cells (PC12). We investigated the expression and aggregation properties of the MPZ protein through immunoblotting, immunohistochemical staining and adhesion assay. MPZ protein with Ile62Phe mutation was immunohistochemically detectable mainly in the plasma membrane of the cells, and it induced a cell aggregation behavior different from the other mutations or the wild-type MPZ. These studies suggested that MPZ Ile62Phe mutation in CMT1B with abnormal myelin folding induced dysregulation of adhesion function of the MPZ protein in a manner unlike those seen in cells with other mutations. The present study provides evidence that the site and nature of amino acid substitutions in the MPZ protein are closely related to the abnormal myelination in CMT1B.
Insights
The MPZ Ile62Phe mutation in Charcot-Marie-Tooth disease type 1B (CMT1B) disrupts myelin by altering MPZ protein adhesion. This specific mutation causes distinct cellular aggregation, unlike other mutations, highlighting site-specific effects on myelination.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Familial Charcot-Marie-Tooth disease (CMT) cases with abnormal myelin folding and MPZ Ile62Phe mutation were previously identified.
- Understanding the molecular mechanisms underlying MPZ mutations in CMT is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the molecular mechanisms of MPZ Ile62Phe mutation in CMT1B.
- To elucidate how MPZ protein expression, aggregation, and adhesion properties are affected by specific mutations.
Main Methods:
- Site-specific mutagenesis was used to create wild-type MPZ, Ile62Phe mutant, and other related mutations (Ser63del, Ser63Cys, Ser63Phe).
- Mutated MPZ proteins were transfected into rat pheochromocytoma (PC12) cells.
- Immunoblotting, immunohistochemical staining, and adhesion assays were employed to analyze MPZ protein expression and function.
Main Results:
- MPZ Ile62Phe mutant protein was detected in the plasma membrane of transfected PC12 cells.
- The Ile62Phe mutation induced a distinct cell aggregation behavior compared to wild-type MPZ and other mutations.
- These findings suggest dysregulation of MPZ protein adhesion function due to the Ile62Phe mutation.
Conclusions:
- The site and nature of amino acid substitutions in the MPZ protein are critical determinants of abnormal myelination in CMT1B.
- The MPZ Ile62Phe mutation uniquely affects MPZ protein adhesion, contributing to the CMT1B phenotype.
- This study provides insights into genotype-phenotype correlations in CMT1B, emphasizing the role of MPZ protein's adhesive properties.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Pleiotropy
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: